0.125 USD
-0.07 (-34.9%)
0.13 USD
+0.01 (+4%)
We assign a fundamental rating of 2 out of 10 to ZYXI. ZYXI was compared to 185 industry peers in the Health Care Equipment & Supplies industry. ZYXI has a bad profitability rating. Also its financial health evaluation is rather negative. ZYXI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ZYXI had negative earnings in the past year.
In the past year ZYXI has reported a negative cash flow from operations.
Each year in the past 5 years ZYXI has been profitable.
Each year in the past 5 years ZYXI had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -163.18%, ZYXI is not doing good in the industry: 90.27% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -163.18% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZYXI's Profit Margin has declined in the last couple of years.
ZYXI's Operating Margin has declined in the last couple of years.
The Gross Margin of ZYXI (71.90%) is better than 81.08% of its industry peers.
In the last couple of years the Gross Margin of ZYXI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ZYXI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.9% |
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
ZYXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZYXI has less shares outstanding
Compared to 5 years ago, ZYXI has less shares outstanding
Compared to 1 year ago, ZYXI has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -2.75, we must say that ZYXI is in the distress zone and has some risk of bankruptcy.
ZYXI's Altman-Z score of -2.75 is on the low side compared to the rest of the industry. ZYXI is outperformed by 64.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.75 |
ROIC/WACCN/A
WACC4.78%
2.3 Liquidity
ZYXI has a Current Ratio of 0.47. This is a bad value and indicates that ZYXI is not financially healthy enough and could expect problems in meeting its short term obligations.
ZYXI has a Current ratio of 0.47. This is amonst the worse of the industry: ZYXI underperforms 93.51% of its industry peers.
A Quick Ratio of 0.32 indicates that ZYXI may have some problems paying its short term obligations.
ZYXI has a Quick ratio of 0.32. This is amonst the worse of the industry: ZYXI underperforms 95.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
ZYXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -540.63%.
Measured over the past years, ZYXI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.77% on average per year.
The Revenue for ZYXI has decreased by -44.13% in the past year. This is quite bad
ZYXI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.42% yearly.
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%
3.2 Future
Based on estimates for the next years, ZYXI will show a very negative growth in Earnings Per Share. The EPS will decrease by -28.28% on average per year.
ZYXI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.81% yearly.
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ZYXI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZYXI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ZYXI's earnings are expected to decrease with -60.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
5. Dividend
5.1 Amount
ZYXI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.125
-0.07 (-34.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners13.78%
Inst Owner Change-27.88%
Ins Owners47.94%
Ins Owner Change0.01%
Market Cap3.80M
Revenue(TTM)108.20M
Net Income(TTM)-73.96M
Analysts82.5
Price Target2.91 (2228%)
Short Float %34.69%
Short Ratio0.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-65.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-176.55%
Min EPS beat(2)-229.01%
Max EPS beat(2)-124.09%
EPS beat(4)0
Avg EPS beat(4)-127.42%
Min EPS beat(4)-229.01%
Max EPS beat(4)-34.8%
EPS beat(8)2
Avg EPS beat(8)-77.04%
EPS beat(12)6
Avg EPS beat(12)-26.42%
EPS beat(16)9
Avg EPS beat(16)-20.44%
Revenue beat(2)0
Avg Revenue beat(2)-31.63%
Min Revenue beat(2)-43.09%
Max Revenue beat(2)-20.18%
Revenue beat(4)0
Avg Revenue beat(4)-23.68%
Min Revenue beat(4)-43.09%
Max Revenue beat(4)-15.48%
Revenue beat(8)0
Avg Revenue beat(8)-15.48%
Revenue beat(12)1
Avg Revenue beat(12)-10.53%
Revenue beat(16)1
Avg Revenue beat(16)-8.43%
PT rev (1m)-37.59%
PT rev (3m)-37.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.43%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-16.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.04 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS3.56
BVpS-1.36
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -163.18% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.9% | ||
| FCFM | N/A |
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.93%
ROCE(5y)15.14%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
F-Score4
Asset Turnover2.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 9.44% | ||
| Cap/Sales | 0.4% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | -2.75 |
F-Score4
WACC4.78%
ROIC/WACCN/A
Cap/Depr(3y)18.03%
Cap/Depr(5y)28.76%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.58%
Profit Quality(3y)218.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
EBIT growth 1Y-519.9%
EBIT growth 3Y-35.57%
EBIT growth 5Y-11.61%
EBIT Next Year-252.95%
EBIT Next 3Y-38.41%
EBIT Next 5Y-9.53%
FCF growth 1Y-234.51%
FCF growth 3Y24.19%
FCF growth 5Y14.61%
OCF growth 1Y-225.94%
OCF growth 3Y22.32%
OCF growth 5Y15.09%
ZYNEX INC / ZYXI FAQ
What is the ChartMill fundamental rating of ZYNEX INC (ZYXI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ZYXI.
What is the valuation status of ZYNEX INC (ZYXI) stock?
ChartMill assigns a valuation rating of 0 / 10 to ZYNEX INC (ZYXI). This can be considered as Overvalued.
What is the profitability of ZYXI stock?
ZYNEX INC (ZYXI) has a profitability rating of 3 / 10.
Can you provide the financial health for ZYXI stock?
The financial health rating of ZYNEX INC (ZYXI) is 1 / 10.
What is the earnings growth outlook for ZYNEX INC?
The Earnings per Share (EPS) of ZYNEX INC (ZYXI) is expected to decline by -1584.67% in the next year.